×ðÁú¿­Ê±

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
Customer Center
¿Í»§ÖÐÐÄ

°²Ñ×´ïÒ½Ò©Íê³ÉPre-AÂÖÈÚ×Ê£¬ÍƽøÃâÒßÑ×Ö¢ÐÂÒ©Ñз¢ | 1·ÖÖÓÒ©ÎÅËÙÀÀ

2025-01-24
|
»á¼ûÁ¿£º

1. 1ÔÂ22ÈÕ£¬º£Ë¼¿ÆÍ¨¸æ£¬¹«Ë¾ÓÚ¿ËÈÕÊÕµ½¹ú¼ÒÒ©Æ·¼àÊÓÖÎÀí¾ÖÏ·¢µÄ¡¶Ò©ÎïÁÙ´²ÊÔÑéÅú׼֪ͨÊé¡·£¬ÔÞ³ÉHSK44459Ƭ¿ªÕ¹°×Èû²¡µÄÁÙ´²ÊÔÑé¡£HSK44459ƬÊǹ«Ë¾×ÔÖ÷Ñз¢µÄȫоßÓÐ×ÔÁ¦ÖªÊ¶²úȨµÄÖÎÁư×Èû²¡µÄÒ©Îï¡£

2. 1ÔÂ22ÈÕ£¬CDE¹ÙÍø¹«Ê¾£¬¿µÏ£ÅµÉúÎïÉ걨µÄÎü¸½ÎÞϸ°û°Ù£¨Èý×é·Ö£©°×ÆÆÁªºÏÒßÃçÉÏÊÐÉêÇëÄâÄÉÈëÓÅÏÈÉóÆÀ¡£ÕâÊÇ¿µÏ£ÅµÉúÎïÑз¢µÄÓ¤Ó×¶ùÓÃÎü¸½ÎÞϸ°û°Ù£¨×é·Ö£©°×ÆÆÁªºÏÒßÃç¡£

3. 1ÔÂ21ÈÕ£¬ÒÔÁëÒ©ÒµÐû²¼Í¨¸æ³Æ£¬ÆäÈ«×Ê×Ó¹«Ë¾±±¾©ÒÔÁëÒ©ÒµÓÐÏÞ¹«Ë¾ÊÕµ½¹ú¼ÒÒ©Æ·¼àÊÓÖÎÀí¾ÖÅú׼ǩ·¢µÄ¡¶Ò©Æ·×¢²áÖ¤Êé¡·£¬Óɱ±¾©ÒÔÁëÌá½»µÄÖÐÒ©1.1ÀàÁ¢ÒìÒ©ÜηÀ±ÇͨƬÐÂÒ©ÉÏÊÐ×¢²áÉêÇëÒÑ»ñÕýʽÅú×¼¡£

4. 1ÔÂ20ÈÕ£¬NMPA¹ÙÍø¹«Ê¾£¬½­Î÷Ê©ÃÀÒ©Òµ¹É·ÝÓÐÏÞ¹«Ë¾É걨µÄÆÕÈð°ÍÁÖ¿Ú±ÀƬ»ñÅúÉÏÊУ¬ÊÓͬ¹ýÆÀ¡£¹ûÕæ×ÊÁÏÏÔʾ£¬ÆÕÈð°ÍÁÖÊÇÐÂÒ»´úÉñ¾­Í´ÖÎÁÆÒ©ÎÖ÷ÒªÊÊÓÃÓÚÌÇÄò²¡ÐÔÍâÖÜÉñ¾­Í´¡¢´ø×´ðåÕîºóÒÅÉñ¾­Í´¡¢ÏËά¼¡Í´¡¢¼¹ËèËðÉËÐÔÉñ¾­Í´¡£

ͶÈÚÒ©ÊÂ

1. 1ÔÂ22ÈÕ£¬°²Ñ×´ïÒ½Ò©Ðû²¼Íê³ÉÓɸߴ´Ïª´´Í¶¶À¼ÒÁìͶµÄÊýÍòÍòÔªÈËÃñ±ÒPre-AÂÖÈÚ×Ê¡£Æ¾Ö¤ÐÂΟ壬±¾ÂÖÈÚ×Ê¿î×Ó½«Ö÷ÒªÓÃÓÚÖ§³Ö°²Ñ×´ï½¹µã¹ÜÏßMAX-001ÔÚÖйú/°Ä´óÀûÑÇÖÎÁÆÍíÆÚÄÑÖÎÐÔʵÌåÖ×ÁöµÄÊ×´ÎÈËÌåÁÙ´²ÊÔÑé¡£

¿Æ¼¼Ò©ÑÐ

1. 1ÔÂ16ÈÕ£¬Ç廪´óѧÆîº£½ÌÊÚ¡¢±±¾©Í¬ÈÊÒ½ÔºÕÅÂÞ½ÌÊÚ¡¢Ç廪´óѧÍõ½¨±ó¸±½ÌÊÚ¡¢Ç廪´óѧÁõÐÀ¸±Ñо¿Ô±ÔÚNature½ÒÏþÅäºÏͨѶ×÷ÕßÂÛÎÄ£¬GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases£¬Í¨¹ýÑо¿ÈËÀàÂýÐÔ±Çñ¼Ñ×±ÇÏ¢ÈâÅжϳöÒ»ÀàÓ°ÏóÐÔCD8+ Tϸ°û¾ßÓÐÔö½øÑ×Ö¢µÄй¦Ð§£¬·¢Ã÷Á˲¹Ìå±»CD8+ Tϸ°û¼¤»îµÄÐÂͨ·£¬Õ¹ÏÖÁ˹ýÃôºÍÆøµÀÑ×Ö¢¼²²¡Ç¨ÑÓ¸´·¢µÄÈ«ÐÂÃâÒßѧ»úÖÆºÍ¼²²¡ÖÎÁÆÐ°еã¡£

[1]Lan, F., Li, J., Miao, W. et al. GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases. Nature (2025). https://doi.org/10.1038/s41586-024-08395-9

Ïà¹ØÐÂÎÅ
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿